Active energy ray-curable composition, cured product thereof, and optical adhesive sheet
A composition with inorganic oxide particles and (meth)acrylate achieves a low glass transition temperature, addressing tackiness and adhesiveness issues in optical adhesive sheets, maintaining high refractive index and flexibility.
Patent Information
- Application Number
- JP2023084691
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-23
- Publication Date
- 2024-12-05
AI Technical Summary
Existing optical adhesive sheets with high refractive index compounds and inorganic particles suffer from increased glass transition temperature (Tg), leading to reduced tackiness and adhesiveness after curing.
A composition containing inorganic oxide particles, (meth)acrylate, and a photopolymerization initiator is formulated to achieve a glass transition temperature (Tg) of -2°C or less, maintaining tackiness and flexibility in the cured product.
The composition maintains high refractive index and tackiness in the cured product, ensuring flexibility and restorability, suitable for optical adhesive sheets.
Smart Images

Figure 2024168211000005 
Figure 2024168211000006 
Figure 2024168211000001
Abstract
Description
[Technical field]
[0001] The present invention relates to an active energy ray-curable composition, a cured product thereof, and an optical adhesive sheet. [Background technology]
[0002] In recent years, in displays such as organic electroluminescence display devices, optical adhesive sheets are used to bond components such as cover glass, metal mesh films, and polarizing plates. Usually, such optical adhesive sheets are produced by curing a photocurable resin composition sandwiched between release sheets. If the optical adhesive sheet has high light transmittance and a high refractive index, the difference in refractive index with the components is small, thereby increasing the light extraction efficiency. In addition, from the viewpoint of reducing the amount of solvent used in the process and reducing the energy required for pre-baking, it is preferable that the material used for the optical adhesive sheet does not contain a solvent (for example, Patent Document 1). On the other hand, a photocurable resin composition that has a low viscosity even without the incorporation of a solvent and has an improved refractive index, and a high refractive cured resin obtained by photocuring the photocurable resin composition, have been disclosed (for example, Patent Document 2). In order to improve the refractive index, methods have been proposed in which a high refractive index compound is used or inorganic high refractive index particles are added. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] Patent No. 7116545 [Patent Document 2] JP 2017-128688 A Summary of the Invention [Problem to be solved by the invention]
[0004] However, compounds with high refractive index and inorganic particles generally increase the glass transition temperature (Tg) of the cured resin, which deteriorates the tackiness and adhesion of the optical adhesive sheet. Therefore, there has been a demand for a material that has a high refractive index and maintains tackiness even after curing.
[0005] The present invention has been made to solve the above-mentioned problems, and aims to provide an active energy ray-curable composition having a high refractive index and tackiness even after curing, by setting the Tg after curing of a composition containing inorganic oxide particles, (meth)acrylate, and a photopolymerization initiator to -2°C or less, and a cured product and an optical adhesive sheet thereof. [Means for solving the problem]
[0006] The present disclosure includes the following embodiments. [1] An active energy ray-curable composition comprising inorganic oxide particles (A) and a (meth)acrylate (B), The refractive index of the active energy ray-curable composition is 1.6 or more, The active energy ray-curable composition, wherein a cured product of the active energy ray-curable composition has a glass transition temperature Tg of -2°C or lower. [2] The active energy ray-curable composition according to [1], further comprising a photopolymerization initiator (C). [3] The active energy ray-curable composition according to [1] or [2], wherein the inorganic oxide particles (A) are zirconia particles. [4] The active energy ray-curable composition according to any one of [1] to [3], wherein the (meth)acrylate (B) includes a (meth)acrylate (B-1) having a polymer Tg of −2° C. or lower. [5] The (meth)acrylate (B) contains at least two types of (meth)acrylate, The active energy ray-curable composition according to [4], wherein the two types of (meth)acrylates further include a (meth)acrylate (B-2) different from the (meth)acrylate (B-1). [6] The active energy ray-curable composition according to any one of [1] to [5], further comprising a dispersant (D). [7] The active energy ray-curable composition according to [6], wherein the dispersant (D) contains a phosphate ester compound. [8] The active energy ray-curable composition according to any one of [1] to [7], wherein a glass transition temperature Tg of a cured product of the active energy ray-curable composition is −5° C. or lower. [9] The active energy ray-curable composition according to any one of [1] to [8], which is for use in an optical adhesive sheet.
[10] A cured product of the active energy ray-curable composition according to any one of [1] to [8], having a glass transition temperature Tg of -2°C or lower.
[11] An optically adhesive sheet comprising the cured product described in
[10] . Effect of the Invention
[0007] According to the present invention, it is possible to provide an active energy ray-curable composition having a high refractive index, which has tackiness even after curing, is highly flexible and has large recovery, and a cured product and an optical adhesive sheet thereof. [Brief description of the drawings]
[0008] [Figure 1] FIG. 1 is a cross-sectional view of an optical pressure-sensitive adhesive sheet (cured product) according to one embodiment of the present invention. [Diagram 2] FIG. 2 is a schematic diagram for explaining the method for evaluating the microhardness. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] The present invention will be described in more detail below. Note that the present invention is not limited to the following embodiments.
[0010] The symbol "to" means greater than or equal to the value before "to" and less than or equal to the value after "to". "(Meth)acrylic" is a general term for acrylic and methacrylic, and "(meth)acrylate compound (B)" is a general term for acrylate compounds and methacrylate compounds.
[0011] (Active energy ray-curable composition) The active energy ray curable composition according to this embodiment contains inorganic oxide particles (A) and a (meth)acrylate compound (B). The active energy ray curable composition has a refractive index of 1.6 or more. The cured product of the active energy ray curable composition has a glass transition temperature Tg of -2°C or less. The active energy ray curable composition according to this embodiment preferably further contains a photopolymerization initiator (C).
[0012] [Inorganic oxide particles (A)] The inorganic oxide particles (A) according to the present embodiment are preferably one or more selected from the group consisting of zirconia, silica, barium sulfate, zinc oxide, barium titanate, cerium oxide, alumina, and titanium oxide. The inorganic oxide particles (A) according to the present embodiment are preferably zirconia particles. The inorganic oxide particles (A) according to this embodiment are not particularly limited in terms of crystal structure. For example, in the case of zirconia particles, a monoclinic system is preferred since it provides a cured product with excellent dispersion stability, light transmittance and refractive index.
[0013] The inorganic oxide particles (A) according to the present embodiment may be any of the known ones, and the shape of the particles is not particularly limited, but may be, for example, spherical, hollow, porous, rod-like, plate-like, fibrous, or amorphous. Among them, spherical is preferable because it has excellent dispersion stability and can provide a cured product with high light transmittance and refractive index.
[0014] <Zirconia nanoparticles> The inorganic oxide particles (A) according to the present embodiment are more preferably zirconia nanoparticles.The zirconia nanoparticles can be generally known, and the shape of the particles is not particularly limited, but can be, for example, spherical, hollow, porous, rod-like, fibrous, etc., and among these, spherical is preferred. The average primary particle size of the zirconia nanoparticles according to this embodiment is preferably 1 to 50 nm, more preferably 1 to 30 nm. Furthermore, the crystal structure is not particularly limited, but is preferably a monoclinic system. The average primary particle size in the present invention can be measured by a method of directly measuring the size of the primary particles from an electron micrograph using a TEM (transmission electron microscope). For example, the measurement method includes a method of measuring the minor axis diameter and major axis diameter of each primary particle of an inorganic particle and taking the average of the measurements as the average primary particle size of the primary particles. Specific examples of zirconia nanoparticles according to this embodiment include UEP-100 (average primary particle size: 11 nm) manufactured by Daiichi Kigenso Kagaku Kogyo Co., Ltd. and PCS (average primary particle size: 20 nm) manufactured by Nippon Denko Corporation.
[0015] [(Meth)acrylate compound (B)] The (meth)acrylate compound (B) according to the present embodiment is not particularly limited as long as the refractive index of the active energy ray curable composition prepared using the compound is 1.6 or more, and the glass transition temperature Tg of the cured product of the active energy ray curable composition is -2°C or less. The refractive index may be 1.62 or more, or may be 1.64 or more. The refractive index may be 1.69 or less. The glass transition temperature Tg may be -4°C or less, or may be -9°C or less. Examples of the (meth)acrylate compound (B) according to the present embodiment include monofunctional (meth)acrylate and polyfunctional (meth)acrylate. The (meth)acrylate compound (B) preferably contains 70% by mass or more of monofunctional (meth)acrylate, more preferably 90% by mass or more, and may contain 100% by mass. Examples include monofunctional (meth)acrylate or polyfunctional (meth)acrylate having a (meth)acryloyl group or a (meth)acryloyloxy group, which are conventionally known for forming optical sheets. If necessary, an oligomer or a prepolymer can be used. The monofunctional (meth)acrylate is a monofunctional (meth)acrylate having one active energy ray-curable group, and the polyfunctional (meth)acrylate is a polyfunctional (meth)acrylate having two or more active energy ray-curable groups. In addition, the (meth)acrylate compound (B) according to this embodiment does not include a dispersant (D) having a (meth)acryloyl group, or a silane coupling agent (E) having a (meth)acryloyl group or a (meth)acryloyloxy group, which will be described later.
[0016] The (meth)acrylate (B) preferably contains a (meth)acrylate (B-1) having a polymer Tg of -2°C or less. By using the (meth)acrylate (B-1) having a polymer Tg of -2°C or less, it becomes easy to prepare an active energy ray curable composition having a glass transition temperature Tg of a cured product of -2°C or less. The polymer Tg may be -4°C or less, -5°C or less, or -10°C or less. Also, it may be -150°C or more, or -100°C or more.
[0017] In the present invention, the "polymer Tg" of a monomer compound refers to the Tg (glass transition temperature) of a polymer of the monomer compound, and indicates the boundary temperature at which a resin changes from a glassy state to a rubbery state when heated. Tg can be measured by a method such as differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA), or thermomechanical analysis (TMA).
[0018] The Tg of the cured product of a composition, i.e., the Tg of a copolymer of multiple monomers, becomes lower the more monomers with low homopolymer Tgs are contained. For example, theoretically, the Tg of a copolymer of monomer M containing monomer 1, monomer 2, ..., monomer n can be calculated using the following Fox equation:
[0019]
number
[0020] However, since Tg also varies depending on the polymerization conditions, reaction rate, molecular weight, crosslinking points, and filler, it is difficult to predict the Tg of the nano-inorganic particle-containing composition of the present invention from the homopolymer Tg of each monomer. For example, in Example 3 described below, 2.9 parts by mass of monomer 1 (Tg1 = -32 ° C) and 24.3 parts by mass of monomer 2 (Tg2 = 8 ° C) were used. The theoretical value of Tg of the copolymer of monomer 1 and monomer 2 calculated by the above Fox formula is 3 ° C. However, as shown in Table 1, when 53.6 parts by mass of inorganic particles are included, the actual measured value of Tg of the cured product of Example 1 was -4 ° C.
[0021] The content of the (meth)acrylate (B-1) in the (meth)acrylate (B) according to this embodiment is preferably 2% by mass or more, more preferably 5% by mass or more, and even more preferably 10% by mass or more. The upper limit of the content of the (meth)acrylate (B-1) is not particularly limited, and the higher the value, the better. In terms of balance with the refractive index, it is more preferably 90% by mass or less, and even more preferably 80% by mass or less. The content of the (meth)acrylate (B-1) in the active energy ray curable composition of the present embodiment is preferably 0.5% by mass or more, more preferably 1% by mass or more, and even more preferably 2% by mass or more. The content of the (meth)acrylate (B-1) is preferably 50% by mass or less, more preferably 40% by mass or less, and even more preferably 30% by mass or less.
[0022] The (meth)acrylate (B) may contain at least two types of (meth)acrylates, and the two types of (meth)acrylates may further contain a (meth)acrylate (B-2) different from the (meth)acrylate (B-1). The (meth)acrylate (B-2) is preferably a (meth)acrylate having a polymer Tg of 0°C or higher. The polymer Tg may be 5°C or higher, or 10°C or higher. The polymer Tg may be 50°C or lower.
[0023] The content of the (meth)acrylate (B-2) in the (meth)acrylate (B) according to the present embodiment is preferably 10% by mass or more, more preferably 15% by mass or more, and even more preferably 30% by mass or more. The content of the (meth)acrylate (B-2) is preferably 95% by mass or less, and even more preferably 90% by mass or less.
[0024] The content of the (meth)acrylate (B) in the active energy ray curable composition of the present embodiment is preferably 10% by mass or more, more preferably 15% by mass or more, and even more preferably 20% by mass or more. The content of the (meth)acrylate (B-1) is preferably 60% by mass or less, more preferably 50% by mass or less, and even more preferably 40% by mass or less.
[0025] <Monofunctional (meth)acrylate> The monofunctional (meth)acrylate is a monofunctional (meth)acrylate having one active energy ray-curable group, and may be a chain aliphatic, cyclic alicyclic, or aromatic (meth)acrylate containing a heteroatom such as a halogen atom, a sulfur atom, an oxygen atom, or a nitrogen atom.
[0026] Examples of the monofunctional (meth)acrylate include an aromatic mono(meth)acrylate compound, an aliphatic mono(meth)acrylate compound, an alicyclic mono(meth)acrylate compound, a heterocyclic mono(meth)acrylate compound, and a hydroxyl group-containing mono(meth)acrylate compound. Examples of the monofunctional (meth)acrylate include polyoxyalkylene-modified mono(meth)acrylate compounds in which a polyoxyalkylene chain such as a polyoxyethylene chain, a polyoxypropylene chain, or a polyoxytetramethylene chain has been introduced into the molecular structure of the various mono(meth)acrylate compounds described above; and lactone-modified mono(meth)acrylate compounds in which a structure derived from a (poly)lactone has been introduced into the molecular structure of the various mono(meth)acrylate compounds described above.
[0027] Examples of the aromatic mono(meth)acrylate compound include benzyl(meth)acrylate, phenyl(meth)acrylate, phenoxy(meth)acrylate, phenoxyethyl(meth)acrylate, phenoxyethoxyethyl(meth)acrylate, 2-hydroxy-3-phenoxypropyl(meth)acrylate, phenoxybenzyl(meth)acrylate, biphenylmethyl(meth)acrylate, benzylbenzyl(meth)acrylate, phenylphenoxyethyl(meth)acrylate, phenylphenol(EO)n(meth)acrylate, and phenol(EO)n(meth)acrylate.
[0028] Examples of the aliphatic mono(meth)acrylate compound include methyl(meth)acrylate, ethyl(meth)acrylate, propyl(meth)acrylate, n-butyl(meth)acrylate, isobutyl(meth)acrylate, tert-butyl(meth)acrylate, n-pentyl(meth)acrylate, n-hexyl(meth)acrylate, n-octyl(meth)acrylate, isooctyl(meth)acrylate, and 2-ethylhexyl(meth)acrylate. Examples of the alicyclic mono(meth)acrylate compound include cyclohexyl(meth)acrylate, isobornyl(meth)acrylate, adamantyl mono(meth)acrylate, cyclohexylmethyl(meth)acrylate, cyclohexylethyl(meth)acrylate, dicyclopentanyl(meth)acrylate, dicyclopentanyloxyethyl(meth)acrylate, dicyclopentenyl(meth)acrylate, and dicyclopentenyloxyethyl(meth)acrylate. Examples of the heterocyclic mono(meth)acrylate compound include glycidyl(meth)acrylate and tetrahydrofurfuryl acrylate. Examples of the hydroxyl group-containing mono(meth)acrylate compound include hydroxyethyl(meth)acrylate, hydroxypropyl(meth)acrylate, and hydroxybutyl(meth)acrylate. An example of the lactone-modified mono(meth)acrylate compound is caprolactone-modified tetrahydrofurfuryl(meth)acrylate.
[0029] The monofunctional (meth)acrylates may be used alone or in combination of two or more kinds. The content of the monofunctional (meth)acrylate in the (meth)acrylate compound (B) is 70% by mass, preferably 75% by mass or more, more preferably 80% by mass or more, and even more preferably 85% by mass or more. Also, it is preferably 95% by mass or less, and more preferably 90% by mass or less. When the content of the monofunctional (meth)acrylate is in the above range, the composition has a high refractive index and a low viscosity.
[0030] [(Meth)acrylate (B-1)] The (meth)acrylate (B-1) having a polymer Tg of -2°C or less is preferably a monofunctional (meth)acrylate. When the (meth)acrylate (B-1) is a monofunctional (meth)acrylate, the (meth)acrylate (B-1) may be, for example, one having a polymer Tg of -2°C or less among the monofunctional (meth)acrylates described above. For example, n-butyl (meth)acrylate, hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, hydroxybutyl (meth)acrylate, lauryl (meth)acrylate, isodecyl (meth)acrylate, and tetrahydrofurfuryl (meth)acrylate may be mentioned. Specific examples of the (meth)acrylate (B-1) include EO-modified phenoxyethyl acrylate (n=4) (polymer Tg=-32°C) and 2-ethylhexyl acrylate (polymer Tg=-70°C).
[0031] [(Meth)acrylate (B-2)] The (meth)acrylate (B-2) is preferably a monofunctional (meth)acrylate having a polymer Tg of 0°C or higher. It is preferable to contain an aromatic mono(meth)acrylate compound, and more preferable to contain a compound containing two aromatic rings in one molecule. In this case, the (meth)acrylate (B-2) may be, for example, one of the monofunctional (meth)acrylates described above having a polymer Tg of 0°C or higher. For example, benzyl (meth)acrylate, phenyl (meth)acrylate, phenoxy (meth)acrylate, and phenoxyethyl (meth)acrylate may be mentioned. A specific example of the (meth)acrylate (B-2) is phenoxybenzyl acrylate (polymer Tg=8°C).
[0032] [Multifunctional (meth)acrylate] The (meth)acrylate compound (B) according to this embodiment may or may not contain a polyfunctional (meth)acrylate in addition to the monofunctional (meth)acrylate according to this embodiment.
[0033] The polyfunctional (meth)acrylate is preferably a polyfunctional (meth)acrylate having three or more active energy ray-curable groups, and may be a chain-like aliphatic, cyclic alicyclic or aromatic (meth)acrylacrylate containing a heteroatom such as a halogen atom, a sulfur atom, an oxygen atom or a nitrogen atom.
[0034] Examples of the polyfunctional (meth)acrylate include ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, tripropylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, tetrabutylene glycol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, and the like. acrylate, 1,9-nonanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, dicyclopentanyl di(meth)acrylate, glycerol di(meth)acrylate, neopentyl glycol hydroxypivalate di(meth)acrylate, caprolactone-modified hydroxypivalic acid neopentyl glycol di(meth)acrylate, tetrabromobisphenol A di(meth)acrylate, hydropivalaldehyde-modified trimethylolpropane di(meth)acrylate, bisphenol fluorene di(meth)acrylate, bisphenol fluorene (EO) n Di(meth)acrylate, Bisphenol A (EO) n Di(meth)acrylate, trimethylolpropane (EO) n and polyfunctional (meth)acrylates (B2) such as dipentaerythritol tri(meth)acrylate, 1,4-cyclohexanedimethanol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, glycerol tri(meth)acrylate, alkyl-modified dipentaerythritol tri(meth)acrylate, pentaerythritol tetraacrylate, ditrimethylolpropane tetra(meth)acrylate, epoxy (meth)acrylate, urethane (meth)acrylate, and polyester (meth)acrylate.
[0035] These polyfunctional (meth)acrylates can be used alone or in combination of two or more. Among these, trimethylolpropane tri(meth)acrylate, ethoxylated trimethylolpropane tri(meth)acrylate, ditrimethylolpropane tetra(meth)acrylate, a reaction product of pentaerythritol and acrylic acid, a reaction product of dipentaerythritol and acrylic acid, and the like are preferred, since they provide a (meth)acrylic resin excellent in drying property, ink fluidity, and suitability for high-speed printing.
[0036] [Photopolymerization initiator (C)] The photopolymerization initiator (C) according to the present embodiment is not particularly limited as long as it has a function of initiating polymerization of the (meth)acryloyl group of the (meth)acrylate compound (B) according to the present embodiment by photoexcitation, and examples thereof include intramolecular bond cleavage type photopolymerization initiator (C) and intramolecular hydrogen abstraction type photopolymerization initiator (C). For example, monocarbonyl compounds, dicarbonyl compounds, acetophenone compounds, benzoin ether compounds, acylphosphine oxide compounds, aminocarbonyl compounds, etc. can be used.
[0037] Examples of the intramolecular bond cleavage type photopolymerization initiator (C) include acetophenones such as diethoxyacetophenone, 2-hydroxy-2-methyl-1-phenylpropan-1-one, benzyl dimethyl ketal, 1-(4-isopropylphenyl)-2-hydroxy-2-methylpropan-1-one, 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone, 1-hydroxycyclohexyl-phenyl ketone, 2-methyl-2-morpholino(4-thiomethylphenyl)propan-1-one, and 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)-butanone; benzoins such as benzoin methyl ether and benzoin isopropyl ether; acylphosphine oxides such as 2,4,6-trimethylbenzoin diphenylphosphine oxide; and benzyl and methylphenyl glyoxyesters.
[0038] Examples of the intramolecular hydrogen abstraction type photopolymerization initiator (C) include benzophenones such as benzophenone, o-benzoyl methylbenzoate-4-phenylbenzophenone, 4,4'-dichlorobenzophenone, hydroxybenzophenone, 4-benzoyl-4'-methyl-diphenyl sulfide, acrylated benzophenone, 3,3',4,4'-tetra(t-butylperoxycarbonyl)benzophenone, and 3,3'-dimethyl-4-methoxybenzophenone; thioxanthones such as 2-isopropylthioxanthone, 2,4-dimethylthioxanthone, 2,4-diethylthioxanthone, and 2,4-dichlorothioxanthone; aminobenzophenones such as Michler's ketone and 4,4'-diethylaminobenzophenone; 10-butyl-2-chloroacridone, 2-ethylanthraquinone, 9,10-phenanthrenequinone, and camphorquinone. The photopolymerization initiator (C) is preferably 2,4,6-trimethylbenzoyldiphenylphosphine oxide.
[0039] Commercially available products of the photopolymerization initiator (C) include Omnirad-184, 651, 500, 907, 127, 369, 784, 2959, and TPO-H manufactured by IGM-Resins; and Esacure ONE manufactured by DKSH Japan Co., Ltd. Omnirad-907 and Omnirad-TPO-H are preferred from the viewpoint of obtaining a cured coating film with excellent curability even with a small amount added. Omnirad-184 is particularly preferred from the viewpoint of less coloring.
[0040] The photopolymerization initiator (C) is not limited to the above compounds, and may be any compound that can initiate polymerization by ultraviolet light. These photopolymerization initiators (C) may be used alone or in combination of two or more. The amount of the photopolymerization initiator (C) used is not particularly limited, but is preferably 0.1 to 10 parts by mass, more preferably 1 to 5 parts by mass, based on 100 parts by mass of the total nonvolatile content of the active energy ray-curable composition of the present embodiment. A known organic amine or the like may also be added as a sensitizer. Furthermore, in addition to the above radical polymerization initiator, a cationic polymerization initiator can also be used in combination.
[0041] A specific example of the photopolymerization initiator (C) according to this embodiment is Runtecure 1108 (manufactured by Runtec Chemical Co., Ltd., structural formula or compound name: 2,4,6-trimethylbenzoyldiphenylphosphine oxide).
[0042] The content of the photopolymerization initiator (C) is preferably 0.1 to 10% by mass, and more preferably 0.5 to 5% by mass, based on the non-volatile mass of the composition. The non-volatile mass of a composition is the total mass of all components of the composition excluding the solvent contained in the composition.
[0043] [Dispersant (D)] The active energy ray-curable composition of the present embodiment preferably further contains a dispersant (D), and the dispersant (D) more preferably contains a phosphoric acid ester.
[0044] <Phosphate ester> The phosphate ester according to the present embodiment is not particularly limited, but examples thereof include those having a polyester chain and those having a (meth)acryloyl group. Examples of those having a polyester chain include DISPERBYK-110 and DISPERBYK-111 (manufactured by BYK Japan KK).
[0045] Furthermore, examples of compounds having a (meth)acryloyl group include those represented by the following structural formula (1), because the resulting inorganic particle dispersion has excellent dispersion stability, and the curable composition containing the compound has a low viscosity and can form a cured coating film having high refractive index performance and excellent bleed-out resistance.
[0046] [ka] (R in the formula 1 is a hydrogen atom or a methyl group, and R 2 is an alkylene chain having 2 to 4 carbon atoms. In addition, x is an integer of 4 to 10, y is an integer of 1 or more, and n is an integer of 1 to 3.
[0047] The phosphoric acid ester compound represented by the structural formula (1) above can form a cured coating film having low viscosity, high refractive index performance, and excellent bleed-out resistance in the obtained active energy ray-curable composition, so that x in the formula is preferably 4 or 5, and y is preferably an integer of 2 to 7. The dispersant (D) represented by the structural formula (1) above may be a mixture in which n in the formula is 1, 2, and / or 3.
[0048] The content of the phosphate ester compound in the active energy ray-curable composition is more preferably in the range of 5 to 40 parts by mass, and even more preferably in the range of 10 to 25 parts by mass, per 100 parts by mass of zirconia, because a cured coating film having high refractive index performance and excellent bleed-out resistance can be formed.
[0049] [Silane coupling agent (E)] The active energy ray curable composition of the present embodiment may further contain a silane coupling agent (E). Examples of the silane coupling agent (E) according to the present embodiment include (meth)acryloyloxy-based silane coupling agents such as 3-(meth)acryloyloxypropyltrimethylsilane, 3-(meth)acryloyloxypropylmethyldimethoxysilane, 3-(meth)acryloyloxypropyltrimethoxysilane, 3-(meth)acryloyloxypropylmethyldiethoxysilane, and 3-(meth)acryloyloxypropyltriethoxysilane; Vinyl-based silane coupling agents such as allyltrichlorosilane, allyltriethoxysilane, allyltrimethoxysilane, diethoxymethylvinylsilane, trichlorovinylsilane, vinyltrichlorosilane, vinyltrimethoxysilane, vinyltriethoxysilane, and vinyltris(2-methoxyethoxy)silane; Epoxy-based silane coupling agents such as diethoxy(glycidyloxypropyl)methylsilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxysilane, 3-glycidoxypropyltrimethoxysilane, 3-glycidoxypropylmethyldiethoxysilane, and 3-glycidoxypropyltriethoxysilane; Styrene-based silane coupling agents such as p-styryltrimethoxysilane; Amino-based silane coupling agents such as N-2(aminoethyl)3-aminopropylmethyldimethoxysilane, N-2(aminoethyl)3-aminopropyltrimethoxysilane, N-2(aminoethyl)3-aminopropyltriethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylidene)propylamine, and N-phenyl-3-aminopropyltrimethoxysilane; ureido-based silane coupling agents such as 3-ureidopropyltriethoxysilane; Chloropropyl-based silane coupling agents such as 3-chloropropyltrimethoxysilane; mercapto-based silane coupling agents such as 3-mercaptopropylmethyldimethoxysilane and 3-mercaptopropyltrimethoxysilane; Sulfide-based silane coupling agents such as bis(triethoxysilylpropyl)tetrasulfide; Isocyanate-based silane coupling agents such as 3-isocyanatepropyltriethoxysilane; Examples of the aluminum-based silane coupling agent include acetoalkoxyaluminum diisopropylate. The silane coupling agent (E) according to the present embodiment is preferably a (meth)acryloyloxy-based silane coupling agent such as 3-(meth)acryloyloxypropyltrimethoxysilane. A specific example of 3-(meth)acryloyloxypropyltrimethoxysilane is the silane coupling agent KBM-503 (manufactured by Shin-Etsu Silicone) having a methacryl group. These silane coupling agents (E) can be used alone or in combination of two or more. Among these, 3-(meth)acryloyloxypropyltrimethoxysilane is preferred because of its good compatibility with the acrylate compound (B). The amount of the silane coupling agent (E) used in this embodiment is preferably in the range of 10 to 30 parts by mass per 100 parts by mass of zirconia, since the obtained active energy ray-curable composition has excellent dispersion stability, and can form a cured coating film having low viscosity, high refractive index performance, and excellent bleed-out resistance.
[0050] [Additives] In addition to the components described above, various additives can be used in the active energy ray-curable composition of the present embodiment at any stage of the production process within a range that does not deviate from the object of the present invention. Examples of such additives that can be used include known additives such as foam stabilizers, antioxidants, defoamers, fillers, pigments, dyes, colorants, thickeners, surfactants, flame retardants, plasticizers, lubricants, antistatic agents, heat stabilizers, tackifiers, curing catalysts, stabilizers, and waxes. If necessary, conventionally known thermoplastic resins, thermosetting resins, and the like can be appropriately selected and used as blend resins within the scope of the present invention. The above additives are merely examples, and the types and amounts of them used are not particularly limited as long as they do not impair the objectives of the present invention. Specific examples of the plasticizer include dioctyl phthalate (DOP), dibutyl phthalate (DBP), dioctyl adipate, isodecyl succinate, diethylene glycol dibenzoate, pentaerythritol ester, butyl oleate, methyl acetylricinoleate, tricresyl phosphate, trioctyl phosphate, propylene glycol polyester adipate, butylene glycol polyester adipate, etc. These may be used alone or in combination of two or more.
[0051] [solvent] The active energy ray-curable composition of the present embodiment may contain a solvent. The solvent is not particularly limited, and various known organic solvents can be used.Specific examples include cyclohexanone, methyl isobutyl ketone, methyl ethyl ketone, acetone, acetylacetone, toluene, xylene, n-butanol, isobutanol, tert-butanol, n-propanol, isopropanol, ethanol, methanol, 3-methoxy-1-butanol, 3-methoxy-2-butanol, ethylene glycol monomethyl ether, ethylene glycol mono n-butyl ether, 2-ethoxyethanol, 1-methoxy-2-propanol, diacetone alcohol, ethyl lactate, butyl lactate, propylene glycol monomethyl ether, ethylene glycol monobutyl ether acetate, propylene glycol monomethyl ether acetate, 2-ethoxyethyl acetate, butyl acetate, isoamyl acetate, dimethyl adipate, dimethyl succinate, dimethyl glutarate, tetrahydrofuran, and methylpyrrolidone.Of these, methyl ethyl ketone is preferred. These organic solvents may be used in combination of two or more kinds. The active energy ray-curable composition of the present embodiment may contain, for example, a solvent used in synthesizing each resin. In addition, the active energy ray-curable composition of the present embodiment may be prepared by mixing the inorganic oxide particles (A), a solvent, and any optional components to prepare an inorganic oxide particle (A) dispersion, and then mixing the inorganic oxide particle (A) with the (meth)acrylate compound (B) and, if necessary, the photopolymerization initiator (C). The above-mentioned example of containing a solvent is just one example, and even if a solvent is contained in the process of preparing the active energy ray curable composition of the present embodiment, it is preferable that the solvent is finally evaporated and the content of the solvent is as small as possible. Therefore, when the active energy ray curable composition of the present embodiment contains a solvent, the content of the solvent in the active energy ray curable composition is preferably 0 to 5 mass%, more preferably 0 to 0.1 mass%.
[0052] [Viscosity of active energy ray-curable composition] The viscosity of the active energy ray-curable composition of the present embodiment at 25°C is preferably 50,000 mPa·s or less, more preferably 15,000 mPa·s or less, and even more preferably 6,000 mPa·s or less. It may also be 1,000 mPa·s or more. If it is within this range, the composition is suitable for film formation.
[0053] [Method for preparing active energy ray-curable composition] The method for preparing the active energy ray curable composition of the present embodiment is not particularly limited. For example, a method of preparing the composition by mixing the dispersion of the inorganic oxide particles (A) with the (meth)acrylate (B), the photoinitiator (C), and, if necessary, various other additives, may be mentioned. Furthermore, in the case of using commercially available inorganic oxide particles (A), the active energy ray-curable composition of the present embodiment can be produced by mixing a dispersion of the inorganic oxide particles (A), the (meth)acrylate (B), the photoinitiator (C), and, if necessary, various other additives. A method for producing the active energy ray-curable composition of the present embodiment preferably includes the steps of: preparing a dispersion of inorganic oxide particles (A); and mixing the dispersion of inorganic oxide particles (A), the (meth)acrylate (B), a photoinitiator (C), and, as necessary, various other additives. The mixing method is not particularly limited, but may be, for example, a method using a media type wet disperser.
[0054] In the step of preparing a dispersion of inorganic oxide particles (A), at least a portion of the monofunctional (meth)acrylate and, if necessary, at least a portion of the polyfunctional (meth)acrylate (B2) may be added.
[0055] <Inorganic oxide particle (A) dispersion> The inorganic oxide particle (A) dispersion according to this embodiment preferably contains, for example, the inorganic oxide particles (A), the solvent, and the dispersant (D) as the additive. The inorganic oxide particle (A) dispersion according to this embodiment may further contain at least a portion of the (meth)acrylate (B). The dispersant (D) may have an acid value in the range of 50 to 300 mgKOH / g. The dispersant (D) generally tends to cause aggregation of inorganic nano particles in the system due to interactions between the inorganic oxide particles (A) and other resin components contained in the active energy ray curable composition of the present embodiment, leading to a decrease in the stability of the active energy ray curable composition during storage and a decrease in the transparency of the cured coating film. By using a dispersant (D) having an acid value in the range of 50 to 300 mgKOH / g, a curable composition having excellent stability over time can be obtained, and the cured product not only has a high refractive index, but also has excellent light transmittance and scratch resistance. The inorganic oxide particle (A) dispersion according to this embodiment preferably further contains the silane coupling agent (E) as the additive. The above-mentioned various silane coupling agents (E) can be used to introduce functional groups onto the surfaces of the inorganic oxide particles (A).
[0056] The method for producing the inorganic oxide particle (A) dispersion according to this embodiment is not particularly limited, and examples thereof include a method for producing the dispersion by dispersing raw materials containing the inorganic oxide particle (A), the dispersant (D), and, if necessary, the silane coupling agent (E) in a media-type wet disperser.
[0057] The media-type wet disperser used in the production method can be any known one without any restrictions, and examples thereof include a bead mill (Star Mill LMZ-015 manufactured by Ashizawa Finetech Co., Ltd., Ultra Apex Mill UAM-015 manufactured by Kotobuki Industries Co., Ltd., etc.).
[0058] The media used in the disperser is not particularly limited as long as it is a commonly known bead, but preferably includes zirconia, alumina, silica, glass, silicon carbide, and silicon nitride. The average particle size of the media is preferably 50 to 500 μm, and more preferably 50 to 200 μm. If the particle size is 50 μm or more, the impact force on the raw material powder is appropriate, and dispersion does not require excessive time. On the other hand, if the particle size of the media is 500 μm or less, the impact force on the raw material powder is appropriate, so that an increase in the surface energy of the dispersed particles can be suppressed and re-agglomeration can be prevented.
[0059] In addition, the dispersion process time can be shortened by using a two-stage method in which large-particle size media with a large impact force is used in the initial stage of grinding the raw material powder, and then small-particle size media that are less likely to re-agglomerate are used after the particle size of the dispersed particles has become smaller.
[0060] In addition, it is preferable to use media that has been thoroughly polished in order to prevent a decrease in the light transmittance of the resulting dispersion.
[0061] In the manufacturing method using the media-type wet disperser, the order in which the raw materials are charged into the disperser is not particularly limited, but by supplying at least the dispersant (D) last, a curable composition excellent in dispersion stability can be obtained using a small amount of dispersant (D). More specifically, the raw materials other than the dispersant (D) are charged first, and after performing operations such as mixing or pre-dispersion, the dispersant (D) is charged last, and the main dispersion step is performed.
[0062] After dispersion is completed, various additives may be added depending on the application, or volatile components may be distilled off to obtain the curable composition of the present invention.
[0063] In addition, the particle diameter (average particle diameter) of the inorganic oxide particles (A) in the inorganic oxide particle (A) dispersion is larger than the average primary particle diameter of the inorganic oxide particles (A) that are the raw material for the inorganic oxide particle (A) dispersion, since the inorganic oxide particles (A) are partially aggregated in the dispersion. Therefore, the average particle size of the inorganic oxide particles (A) in the inorganic oxide particle (A) dispersion is preferably 100 nm or less, and more preferably in the range of 20 to 100 nm, in order to produce a cured product having a high refractive index and excellent light transmittance.
[0064] [Characteristics of active energy ray-curable composition] The refractive index of the active energy ray-curable composition of this embodiment is 1.6 or more, or may be 1.62 or more, or 1.64 or more, or may be 1.69 or less. The active energy ray-curable composition of the present embodiment has a glass transition temperature Tg of -2°C or lower, or may be -4°C or lower, or may be -9°C or lower, or may be -50°C or higher.
[0065] (cured product) The cured product of the present embodiment is a cured product of the active energy ray curable composition of the present embodiment described above. The cured product of the present embodiment can be used for various applications such as optical components such as optical lenses, optical films, anti-reflection materials, thin film sealing materials, optical pressure sensitive adhesives, optical adhesives, diffusion microlenses, and optical pressure sensitive adhesive sheets (pressure sensitive adhesive sheets used to bond display device components). The shape of the cured product of the present embodiment is not particularly limited, and can be selected depending on the application, such as a flat sheet having a smooth surface, a sheet having a fine uneven structure, or a sheet having a curved surface like a concave or convex lens. The cured product of this embodiment can be thinned when used in an optical lens, the difference in refractive index between the transparent electrode and the cured product can be reduced in an optical film to make the transparent electrode less noticeable, the refractive index difference between the transparent electrode and the cured product can be reduced in an optical film to make the transparent electrode less noticeable, and the cured product can be combined with a low refractive index layer to provide an anti-reflection function, and the refractive index (589 nm) at 25°C is preferably 1.62 or more, more preferably 1.65 or more, and even more preferably 1.66 or more, from the viewpoint of improving the light extraction efficiency from the light emitting element in an LED encapsulant. The upper limit of the refractive index is not particularly limited, and the higher the value, the more preferable. If anything, from the viewpoint of the balance with the viscosity, the refractive index is preferably 1.62 to 1.70, and more preferably 1.65 to 1.69. In addition, when used as an adhesive, from the viewpoint of the cured product being flexible and easily conforming to unevenness of the adherend, the maximum indentation depth is preferably 10 μm to 70 μm, more preferably 15 μm to 50 μm. In addition, from the viewpoint of high molecular mobility and enhanced restorability, the elastic deformation power is preferably 60% to 100%, more preferably 75% to 98%.
[0066] [Method of manufacturing the cured product] The method for producing the cured product of the present embodiment is not particularly limited, and includes, for example, a film-forming step of forming a film from the active energy ray-curable composition of the present embodiment on a substrate; and a curing step of irradiating the film of the active energy ray-curable composition obtained in the film-forming step with active energy rays to cure it.
[0067] Examples of a method for forming a film on a substrate such as a transparent film include a coating method. As the coating method, a known method can be used, for example, a method using a rod or wire bar, or various coating methods such as microgravure, gravure, die, curtain, lip, slot, or spin can be used.
[0068] In the method for producing the cured product of this embodiment, for example, the active energy ray curable composition of this embodiment is applied to the release surface of one release sheet 2a (or 2b) to form a coating layer having a predetermined thickness, as shown in Fig. 1. The formed coating layer is then superimposed on the release surface of the other release sheet 2b (or 2a), and the coating layer is then cured by irradiating it with active energy rays from an LED lamp or the like having a wavelength of 365 nm, to form the cured product 1. In another example of producing the cured product 1, a coating solution of a solventless adhesive composition is applied to the release surface of one of the release sheets 2a (or 2b), and the solventless adhesive composition is cured by irradiating with active energy rays to form the cured product 1, and then the release surface of the other release sheet 2b (or 2a) is superimposed on the cured product 1.
[0069] The active energy rays can be used without any particular limitation as long as they are active energy rays that cause the curable composition of the present invention to cure, but it is particularly preferable to use ultraviolet rays.
[0070] Sources of ultraviolet rays include LEDs, fluorescent chemical lamps, black lights, low-pressure, high-pressure, and ultra-high-pressure mercury lamps, metal halide lamps, sunlight, etc. For example, an 80W high-pressure mercury lamp can be used. The irradiation intensity of the ultraviolet light may be constant from start to finish, or the intensity may be changed during the curing process to finely adjust the physical properties after curing. For example, when using an 80 W high-pressure mercury lamp in a nitrogen atmosphere, the ultraviolet light is 0.5 to 3.0 kJ / m 2 It can be irradiated with an energy value of .
[0071] In addition to ultraviolet light, other active energy rays that can be used include visible light and electron beams.
[0072] (Optical adhesive sheet) The optical adhesive sheet of the present embodiment can be formed using the cured product of the present embodiment. The optical adhesive sheet of the present embodiment can also be used as an adhesive sheet used for bonding display device components, for example. The optical adhesive sheet of the present embodiment may be disposed between display device components such as a cover glass, a metal mesh film, a polarizing plate, etc. Since the optical adhesive sheet of the present embodiment has high light transmittance and a high refractive index, the refractive index difference with the component is small, and therefore the light extraction efficiency is high.
[0073] [Method of manufacturing optical adhesive sheet] The method for producing the optical adhesive sheet of this embodiment is not particularly limited, and includes, for example, a step of applying the active energy ray curable composition of this embodiment described above to the substrate, and a step of irradiating the substrate with active energy rays such as ultraviolet rays to form a cured coating film.
[0074] In the method for producing the optical adhesive sheet of the present embodiment, for example, the active energy ray curable composition of the present embodiment is applied to the release surface of one release sheet 2a (or 2b) to form a coating layer having a predetermined thickness, as shown in Fig. 1. The release surface of the other release sheet 2b (or 2a) is then superimposed on the formed coating layer, and the coating layer is then cured by irradiating it with active energy rays from an LED lamp or the like having a wavelength of 365 nm, to form the optical adhesive sheet 1. As another example of manufacturing the optical adhesive sheet 1, a coating solution of a solventless adhesive composition is applied to the release surface of one release sheet 2a (or 2b), and the solventless adhesive composition is cured by irradiating with active energy rays to form the optical adhesive sheet 1, and then the release surface of the other release sheet 2b (or 2a) is superimposed on the optical adhesive sheet 1. EXAMPLES
[0075] The present invention will be described in detail below with reference to examples, but the present invention is not limited thereto. (raw materials) "Zirconia": UEP-100 (manufactured by Daiichi Kigenso Kagaku Kogyo Co., Ltd.) "Zirconia nanoparticle dispersion": Zirconia nanoparticle dispersion, manufactured by Nippon Shokubai, Zircostar (registered trademark) high refractive index nanoparticles ZP-153 "Dispersant (D)" (phosphate ester compound): Dispersant D-1 (a compound represented by the following structural formula (1)
[0076] [ka]
[0077] (In the formula, R 1 is a methyl group, and R 2 is an ethylene chain having 2 carbon atoms, x is 5, y is 2 (average value), and n is an integer from 1 to 3.
[0078] "Silane coupling agent (E)": KBM-503 (Shin-Etsu Chemical Co., Ltd., 3-(trimethoxysilyl)propyl methacrylate)
[0079] "(Meth)acrylate compound (B-1)": EO modified phenoxyethyl acrylate (n=4) (polymer Tg=-32℃), manufactured by MIWON SPECIALTY CHEMICAL CO.,LTD. 2-ethylhexyl acrylate (polymer Tg = -70°C) manufactured by Mitsubishi Chemical
[0080] "(Meth)acrylate compound (B-2)": Phenoxybenzyl acrylate (polymer Tg = 8°C) manufactured by Green Chemical Co., Ltd. Phenylbenzyl acrylate (polymer Tg = 40°C) Shin-Nakamura Chemical
[0081] "Photopolymerization initiator (C)": 2,4,6-trimethylbenzoyldiphenylphosphine oxide, trade name: Runtecure 1108 (manufactured by Runtec Chemical Co., Ltd.) Diethylene glycol dibenzoate: Tokyo Chemical Industry Co., Ltd.
[0082] <Liquid refractive index> The active energy ray-curable composition was directly applied to the prism of the Abbe refractometer, and measurement was carried out at 25° C. Measurement wavelength: 589 nm.
[0083] <Glass transition temperature (Tg)> The active energy ray-curable resin composition was filled between two glass plates using a 125 μm-thick PET film as a spacer, and then cured by irradiating with 2000 mJ / cm2 ultraviolet rays from an LED lamp with a wavelength of 365 nm. The glass plate on the side opposite the irradiated surface was then peeled off to produce a 125 μm-thick flat film-like cured product on the glass plate. The flat film-like cured product was peeled off from the glass substrate, and a DSC curve was measured by dynamic scanning calorimetry (DSC) using a differential scanning calorimeter (X-DSC7000, manufactured by Hitachi High-Tech Science). Temperature rise conditions: 20℃→80℃, 80℃→-50℃, -50℃→80℃ (10℃ / min) Atmosphere: N 2 Bread: Al
[0084] <Film refractive index> The active energy ray curable composition was sandwiched between a glass plate and a transparent, easy-adhesion treated PET film (product name: A4300, thickness: 125 μm, manufactured by Toyobo Co., Ltd.) as a transparent substrate, and then pressed and spread with a rubber hand roller to a thickness of about 10 μm, and then irradiated with active energy rays to cure, and then the PET film was peeled off from the glass plate together with the active energy ray curable resin layer to form a cured coating film of the curable composition on the surface of the substrate. The refractive index of the coating film was measured using a PRISM COUPLER MODEL 2010 / M (manufactured by Metricon Co., Ltd.). "Irradiation conditions" Light source: Ultraviolet light from ultra-high pressure mercury lamp Accumulated light output: 400mJ / cm 2 "Measurement conditions" Wavelength: 594nm Measurement mode: single film
[0085] <Viscosity> The viscosity was evaluated by measuring the viscosity at a temperature of 25° C. using an E-type rotational viscometer ("TVE-25H" manufactured by Toki Sangyo Co., Ltd.).
[0086] <Microhardness> A flat film-shaped cured product with a glass substrate was prepared in the same manner as in the above <Glass transition temperature (Tg)>, and measurements were made using a microhardness tester (product name HM2000) manufactured by Fisher Instruments Co., Ltd. in accordance with ISO 14577-1, except that a flat diamond indenter was used instead of a diamond pyramid indenter. The test conditions were as follows. Plane size of flat indenter: 100μm x 100μm Per second: 20~60mN Maximum compression force: 500mN Dwell time at maximum compression: 5 to 10 seconds F: 500mN / 10s (maximum test force / maximum test force load time required) C: 5.0s (maximum test force holding time) R: 0.1mN / 10s (minimum test force / time required to unload minimum test force) C2: 10.0s (minimum test force holding time) By continuously monitoring the load and indentation depth as shown in the schematic diagram of Figure 2, the following parameters can be obtained. nIt: Elastic deformation power (=W elast / (W elast +W plast )×100)(unit:%) hmax u: Maximum indentation depth (unit: μm) hp u: Permanent indentation depth after removing the test force (unit: μm) CIT1: Indentation creep (=(h 2 -h 1 ) / h 1 ×100) (unit: %)
[0087] <Tackiness> A glass plate was pressed against the flat film-like cured product with a glass substrate prepared in the same manner as above for <Glass transition temperature (Tg)>, and then only the upper glass plate pressed against it was lifted up, and the tackiness was evaluated as follows. ◯: The flat film-like cured product with the glass substrate underneath was lifted up. Δ: The flat film-like cured product with the glass substrate underneath rose temporarily, but then immediately fell. ×: The flat film-like cured product with the glass substrate underneath was not lifted up.
[0088] Example 1 As inorganic oxide particles (A), 55.4 parts by mass of zirconia nanoparticles (manufactured by Daiichi Kigenso Kagaku Kogyo Co., Ltd., product name: UEP-100), As a dispersant (D), 8.3 parts by mass of phosphoric acid ester 1 (a compound represented by the above structural formula (1)), 5.5 parts by mass of 3-(trimethoxysilyl)propyl methacrylate (manufactured by Shin-Etsu Chemical Co., Ltd., product name: KBM-503) as a silane coupling agent (E) and 69.3 parts by mass of methyl ethyl ketone (hereinafter abbreviated as "MEK") as a solvent were mixed and stirred for 30 minutes with a dispersion stirrer to perform coarse dispersion. Next, the resulting mixture was dispersed using zirconia beads with a particle diameter of 100 μm with a media-type wet disperser ("Star Mill LMZ-015" manufactured by Ashizawa Finetech Co., Ltd.). Dispersion was performed for a residence time of 100 minutes while checking the particle diameter during the process, and an inorganic particle dispersion was obtained. To this inorganic particle dispersion, 2.9 parts by mass of 2-ethylhexyl acrylate (polymer Tg = -70 ° C., manufactured by Mitsubishi Chemical) as a (meth)acrylate (B-1) having a polymer Tg of -2 ° C. or less, and 19.0 parts by mass of phenoxybenzyl acrylate (polymer Tg = 8 ° C., manufactured by Green Chemical Co., Ltd.) as a (meth)acrylate (B-2) having a polymer Tg of 0 ° C. or more were added, and the volatile components were removed under reduced pressure while heating with an evaporator. Furthermore, 2.9 parts by mass of 2,4,6-trimethylbenzoyldiphenylphosphine oxide (manufactured by Runtec Chemical Co., Ltd., product name: Runtecure 1108) as a photopolymerization initiator and 5.8 parts by mass of diethylene glycol dibenzoate (manufactured by Tokyo Chemical Industry Co., Ltd.) as an additive were added to prepare an active energy ray curable composition P1 (composition P1) of this embodiment. The liquid refractive index and viscosity of composition P1 were evaluated using the above evaluation method. The film refractive index, microhardness, and tackiness of the cured product of composition P1 were evaluated, and the results are shown in Table 1.
[0089] (Examples 2 to 4, 6, Comparative Examples 1 and 3) In each example, compositions P2 to P4, P6, cP1, and cP3 of Examples 2 to 4, 6, and Comparative Examples 1 and 3 were prepared in the same manner as in Example 1, except that the components and composition ratios shown in Table 1 were used. The amount of MEK used was 2.15 times the amount of inorganic nanoparticles shown in Table 1, as in Example 1. The liquid refractive index and viscosity of each composition were evaluated as in Example 1. In addition, the film refractive index, microhardness, and tackiness of the cured product of each composition were evaluated. The results are shown in Table 1.
[0090] (Example 5, Comparative Example 2) Instead of the prepared inorganic particle dispersion, a zirconia nanoparticle dispersion liquid (Zircostar (registered trademark) high refractive index nanoparticles ZP-153) manufactured by Nippon Shokubai was used to prepare compositions P5 and cP2 of Example 5 and Comparative Example 2, respectively, in the same manner as in Example 1. The amount of MEK used was 2.15 times the amount of inorganic nanoparticles shown in Table 1, as in Example 1. The liquid refractive index and viscosity of each composition were evaluated as in Example 1. In addition, the film refractive index, microhardness, and tackiness of the cured product of each composition were evaluated. The results are shown in Table 1.
[0091] [Table 1]
[0092] (Consideration) As shown in Table 1, in the examples, active energy ray curable compositions with high refractive index and tackiness even after curing and their cured products were obtained. This is because the use of zirconia, which is a high refractive index inorganic particle, and (meth)acrylate (B-1) with a polymer Tg of -2°C or less allows the composition to have a low Tg of -2°C or less even after curing, and maintains a rubbery state even at room temperature. Furthermore, the use of (meth)acrylate (B-2) with a polymer Tg of 0°C or less allows the composition to achieve a high refractive index while maintaining a viscosity that allows easy handling. In Comparative Examples 1, 2, and 3 which did not contain the (meth)acrylate (B-1) having a polymer Tg of −2° C. or less, the Tg after curing was 0° C. or more, and good tackiness was not obtained. Also, as shown in Table 1, in the examples, good tackiness was obtained by setting the maximum indentation depth to 10 μm or more and the elastic deformation power to 60% or more. This is because the maximum indentation depth is large, the cured product is flexible, and follows the irregularities of the glass surface that is the adherend. Furthermore, better tackiness was obtained by setting the maximum indentation depth to 15 μm or more and the elastic deformation power to 75% or more. On the other hand, good tackiness was not obtained in Comparative Examples 1, 2, and 3, in which the maximum indentation depth was less than 10 μm or the elastic deformation power was less than 60%. [Explanation of symbols]
[0093] 1...Adhesive sheet (cured product) 2a, 2b...Release sheet
Claims
1. An active energy ray-curable composition containing inorganic oxide particles (A) and a (meth)acrylate (B), The refractive index of the active energy ray-curable composition is 1.6 or more, The active energy ray-curable composition, wherein the glass transition temperature Tg of a cured product of the active energy ray-curable composition is −2° C. or lower.
2. The active energy ray-curable composition according to claim 1 , further comprising a photopolymerization initiator (C).
3. 3. The active energy ray-curable composition according to claim 1, wherein the inorganic oxide particles (A) are zirconia particles.
4. 3. The active energy ray-curable composition according to claim 1, wherein the (meth)acrylate (B) comprises a (meth)acrylate (B-1) having a polymer Tg of −2° C. or lower.
5. The (meth)acrylate (B) contains at least two types of (meth)acrylates, The active energy ray-curable composition according to claim 4, wherein the two types of (meth)acrylates further include a (meth)acrylate (B-2) different from the (meth)acrylate (B-1).
6. The active energy ray-curable composition according to claim 1 or 2, further comprising a dispersant (D).
7. The active energy ray-curable composition according to claim 6 , wherein the dispersant (D) contains a phosphoric acid ester compound.
8. 3. The active energy ray-curable composition according to claim 1, wherein a glass transition temperature Tg of a cured product of the active energy ray-curable composition is −5° C. or lower.
9. The active energy ray-curable composition according to claim 1 or 2, which is for use in an optical adhesive sheet.
10. 3. A cured product of the active energy ray-curable composition according to claim 1, wherein the cured product has a glass transition temperature Tg of -2°C or lower.
11. An optical pressure-sensitive adhesive sheet comprising the cured product according to claim 10.
Citation Information
Patent Citations
Active energy ray-curable resin composition, cured product thereof, and lens sheet
JP2017128688A
Adhesives, adhesive sheets and displays
JP7116545B2
Hook shaped jar opener
KR1020240049501A
Curable composition, cured product thereof, and optical member
WO2016136454A1
Adhesive film, optical member comprising same, and optical display device comprising same
WO2022092749A1
